In 2024, 37.4% of late-stage assets targeted rare diseases, up from 31.1% in 2023
Thm ch, ngi ta cn chng minh rng protein c th bo v chng li bnh long xng trong khi khng c tc dng ph g i vi thn
You May Need to Use a GLP-1 Indefinitely While we dont yet have good data on what happens when people with MASH stop taking the medication, its reasonable to assume that their excess liver fat and scar tissue may come back, even if your MASH is in remission, says Ali
Preclinical studies suggest GLP-1 receptor signaling can modulate sympathetic outflow and peripheral thermoregulatory responses, although direct human evidence remains limited
J Biol Chem 288: 181191, 2013
Intensive lipid lowering with atorvastatin in coronary disease